Gageostatin A - Gageostatin B

General Information


DRACP ID  DRACP03613

Peptide Name   Gageostatin A - Gageostatin B

Sequence  ELLVDLL,ELLVDLL

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  3-OH-Me-C13,3-OH-DiMe-C13

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C76H130N14O22

Absent amino acids  ACFGHIKMNPQRSTWY

Common amino acids  L

Mass  184188

Pl  3.29

Basic residues  0

Acidic residues  4

Hydrophobic residues  10

Net charge  -4

Boman Index  1638

Hydrophobicity  165.33

Aliphatic Index  246.67

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24492520

Title  Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis

Doi Not available

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  8372

DRACP is developed by Dr.Zheng's team.